Vicore Pharma Holding

11.92 SEK

+9.36 %

Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

+9.36 %
+16.18 %
+11.40 %
+5.49 %
+16.41 %
+44.31 %
-50.20 %
-45.55 %
+136.04 %

Vicore Pharma operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
3.36B SEK
Turnover
14.92M SEK
Revenue
3.82M
EBIT %
-11,851.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21/8
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.